Sun Pharmaceutical may test Rs 930-945: Pankaj Jain

Pankaj Jain of SW Capital told CNBC-TV18, "Hold on to Sun Pharmaceutical Industries. The investor must have also observed that in the last 45 days the kind of correction we have seen in the market, Sun Pharma has been holding on rather it has been one of the positive performer in this market and Rs 910-920 or the zone of Rs 890-920 is a serious resistance level because when the stock had fallen from those plus Rs 1,100 kind of level, this was one area the stock was trying to hold on and once this area was breached, the stock went down all the way levels closer to Rs 750.""The stock has been inching up; the Q3 performance was strong and steady. I think much well than what market expected. I think most of the negatives prevailing in the market with respect to Sun Pharma-Ranbaxy, I think they are already part of this price and we have seen some amount of positive coming back into the bigger pharmaceutical stocks. In next three-four months kind of thing, we expect the stock to see levels somewhere between Rs 930-945," he said.